A hemicyanine-based fluorescence probe for selective detection of CYP2D6 in living cells and tumor-bearing mice
Source abstract
Abstract
Abstract Cytochrome P450 (CYP) 2D6, as the only active CYP2D subfamily enzyme in humans, involved in metabolizing 25% of clinical drugs, including antidepressants, antiarrhythmic drugs, antipsychotics and analgesics. Herein, two novel enzyme-activatable fluorescent probes (McMe and BnMcMe) were constructed and synthesized to monitor the activity of CytochromeP4502D6 (CYP2D6) in complex biological systems. McMe possessed excellent selectivity and sensitivity in response to CYP2D6 enzyme with 9-fold fluorescence changes and the limit of detection (LOD) = 0.052 nM. The fruitful application of McMe in living cells and tumor-bearing mice implied that it can be used to measure the activity of endogenous CYP2D6. These researches indicated that McMe could be served as an effective molecular tool to specifically bio-image the activity of endogenous CYP2D6 in nude mice, which may provide assistance to investigate the function of CYP2D6 in drug metabolism and pathologic process.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Pharmacogenetics and Drug Metabolism · Eicosanoids and Hypertension Pharmacology · Drug Transport and Resistance Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Cytochrome P450 1 family and cancers10.1016/j.jsbmb.2014.11.003 ↗
2. Molecular probes for human cytochrome P450 enzymes: recent progress and future perspectives10.1016/j.ccr.2020.213600 ↗
3. Cytochromes P450 as versatile biocatalysts10.1016/j.jbiotec.2006.01.026 ↗
4. The value of CYP2D6 gene polymorphism in breast cancer
5. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects10.1016/j.pharmthera.2007.09.004 ↗
6. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future10.1016/j.tips.2004.02.007 ↗
7. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme10.1080/03602530903118729 ↗
8. Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers10.1111/j.1365-2710.2009.01102.x ↗
9. A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature10.1038/s41598-017-08404-0 ↗
10. Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro10.2147/DDDT.S106175 ↗
11. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation10.1016/j.pharmthera.2012.12.007 ↗
12. Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype10.1016/j.breast.2014.02.008 ↗
13. Design strategy of multifunctional and high efficient hydrogen sulfide NIR fluorescent probe and its application in vivo10.1016/j.dyepig.2020.108901 ↗
14. Crystal structure of human cytochrome P450 2D610.1074/jbc.M511232200 ↗
15. Dual-emission NIR fluorescent probe sensitive response biological microenvironment and sulfur dioxide
16. The research progress of organic fluorescent probe applied in food and drinking water detection10.1016/j.ccr.2020.213557 ↗
17. A fluorescent bichromophoric “off-on-off” pH probe as a molecular logic device (half-subtractor and digital comparator) operating by controlled PET and ICT processes10.1016/j.dyepig.2018.10.030 ↗
18. Malononitrile as the 'double-edged sword' of passivation-activation regulating two ICT to highly sensitive and accurate ratiometric fluorescent detection for hypochlorous acid in biological system10.1016/j.snb.2020.128793 ↗
19. Rational design of fluorescent probes: improving hydrophilicity, ratiometric and NIR trapping of endogenous leucine aminopeptidase10.1016/j.snb.2020.128631 ↗
20. Facile synthesis of highly sensitive, red‐emitting, fluorogenic dye for micro-viscosity and mitochondrial imaging in embryonic stem cells
21. A near-infrared ratiometric fluorescent probe for selectively tracking human cytochrome P450 3A5 in living cells and tumor-bearing mice10.1016/j.snb.2020.129372 ↗
22. A highly selective ratiometric fluorescent probe based on naphthylamide for detection and imaging of CYP1A1 in living cells and zebrafish10.1039/C9AN01767D ↗
23. A highly selective ratiometric two-photon fluorescent probe for human cytochrome P450 1A10.1021/jacs.5b09854 ↗
24. A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study10.1039/C6SC03970G ↗
25. A tunable palette of molecular rotors allows multicolor, ratiometric fluorescence imaging and direct mapping of mitochondrial heterogeneity10.1021/acsabm.1c00135 ↗
26. Target enzyme-activated two-photon fluorescent probes: a case study of CYP3A4 using a two-dimensional design strategy10.1002/anie.201903683 ↗
27. Compounds as fluorescent probes, synthesis and applications thereof
28. Xiong K M, Huo F J, Chao J B, et al. Colorimetric and NIR fluorescence probe with multiple binding sites for distinguishing detection of Cys/Hcy and GSH in vivo[J]. Anal Chem, 91(2):1472-1478.10.1021/acs.analchem.8b04485 ↗
29. Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations10.1007/s40262-013-0041-1 ↗
30. Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc10.1124/dmd.112.048298 ↗
31. Computational insights into the different catalytic activities of CYP3A4 and CYP3A5 toward schisantherin E10.1111/cbdd.13475 ↗
32. A fluorescence switch for the detection of nitric oxide and histidine and its application in live cell imaging10.1002/cplu.201402217 ↗
33. Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A510.2174/138920008783331121 ↗
34. CYP3A5 polymorphism, amlodipine and hypertension10.1038/jhh.2013.67 ↗
35. Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen
36. Selective metabolism of vincristine in vitro by CYP3A510.1124/dmd.106.009902 ↗
37. Observation of acetylcholinesterase in stress-induced depression phenotypes by two-photon fluorescence imaging in the mouse brain10.1021/jacs.8b11414 ↗
38. Analogs of Changsha near-infrared dyes with large Stokes Shifts for bioimaging10.1016/j.biomaterials.2013.08.081 ↗
39. Hydroxyphenylquinazolinone-based turn-on fluorescent probe for β-galactosidase activity detection and application in living cell10.1016/j.dyepig.2018.04.003 ↗
40. A hemicyanine-based colorimetric turn-on fluorescent probe for β-galactosidase activity detection and application in living cells10.1016/j.jlumin.2018.09.036 ↗
41. Molecular design strategy to construct the near-infrared fluorescent probe for selectively sensing human cytochrome P450 2J210.1021/jacs.8b12136 ↗
42. In situ target enzyme-activated near-infrared fluorescent probe: a case study of CYP2J2 using three-fragmentary molecular assembly engineering10.1016/j.snb.2020.129034 ↗
43. Inhibition of desipramine hydroxylation (cytochrome P450‐2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo
44. Importance of the cytochrome P450-2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol10.1097/00007691-200108000-00007 ↗